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Introduction
Ventilator associated- respiratory infections (VARI) are
the most prevalent in the ICU. The differential diagnosis
of pneumonia (VAP) and tracheobronchitis (TAV) is
overlapping.
Objectives
The aim of this study is to analyze the differences in
presentation and outcome between VAP and TAV in a
large database.
Methods
Analysis of the Spanish ENVIN register 2008 2014 data-
base. Diagnoses definitions included in the manual
(ECDC and CDC). Characteristics of patients with TAV
and NAV, of all episodes of VARI and patient outcomes
were analyzed. Univariate and multivariate analysis were
conducted.
Results
Among 115 966 patients hospitalized > 24 h, 91,122
(78.6%) with full information were analyzed. The 55% of
them (50,212) were ventilated for 498,316 days. In 6699
(7.4% of total and 13.3% of ventilated) 8,131 VARI were
diagnosed of which 4,435 (54.5%) were classified as VAP
and 3,696 as VAT. In 3,433 pts 1 or more episodes of
VAP were identified and TAV in 2,905 pts. Only 361
pts were recorded as having episodes of VAP +VAT.
The incidence was 10.9 VAP x 1000 days of MV and
9.1 VAT x 1000 days of MV.
VAP was significantly more frequent in younger
patients (p < 0.001), with traumatic, OR 1.3 (1.1-1.5)
and medical OR 1.21 (1.1-1.4) pathology and neutrope-
nia OR 1.4 (1.03 to 2.1). No differences in APACHE II
at admission, origin of the patients (community, ward,
nursing homes), use of devices (CVC, UC etc), emer-
gency surgery, extra renal depuration, immunosuppres-
sion or antibiotics at admission or before VARI. Days
prior to the VARI diagnosis were 10.3 (8.8) globally, 9.7
for VAP and (8.6) for VAT. However, systemic inflam-
matory response (RIS) was significantly higher (p <
0.0001) in VAP (severe sepsis 24.2%, septic shock 18.8%)
than in VAT (8 and 3.2%). Regarding the impact on out-
come, the total duration of MV, 23.7 (15.4) vs. 20.6 (15)
days and ICU stay, 27.4 (15.6) vs. 24.5 (15) days were
higher in patients with VAP. Likewise, the crude mortal-
ity rate was higher in patients with VAP, OR 2.4 (95%
CI 2.1 to 2.7), while mortality of patients with VAT was
similar to patients without VARI.
Conclusions
VAT and VAP had a similar incidence, but the presen-
tation of the episodes (RIS) and the impact on the ICU-
stay and mortality are clearly different.
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